Trinity Biotech (NASDAQ:TRIB) Now Covered by StockNews.com
StockNews.com initiated coverage on shares of Trinity Biotech (NASDAQ:TRIB – Get Rating) in a research note published on Tuesday morning. The brokerage issued a buy rating on the stock. Trinity Biotech Stock Performance NASDAQ TRIB opened at $0.94 on Tuesday. The company has a current ratio of 2.69, a quick ratio of 1.39 and a […]